Table of Contents Chapter 1 Heart Failure Drugs Market Overview 1.1 Heart Failure Drugs Definition 1.2 Global Heart Failure Drugs Market Size Status and Outlook (2015-2030) 1.3 Global Heart Failure Drugs Market Size Comparison by Region (2015-2030) 1.4 Global Heart Failure Drugs Market Size Comparison by Type (2015-2030) 1.5 Global Heart Failure Drugs Market Size Comparison by Application (2015-2030) 1.6 Global Heart Failure Drugs Market Size Comparison by Sales Channel (2015-2030) 1.7 Heart Failure Drugs Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Heart Failure Drugs Market Segment Analysis by Player 2.1 Global Heart Failure Drugs Sales and Market Share by Player (2018-2020) 2.2 Global Heart Failure Drugs Revenue and Market Share by Player (2018-2020) 2.3 Global Heart Failure Drugs Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Heart Failure Drugs Market Segment Analysis by Type 3.1 Global Heart Failure Drugs Market by Type 3.1.1 Injection 3.1.2 Capsule 3.1.3 Tablets 3.2 Global Heart Failure Drugs Sales and Market Share by Type (2015-2020) 3.3 Global Heart Failure Drugs Revenue and Market Share by Type (2015-2020) 3.4 Global Heart Failure Drugs Average Price by Type (2015-2020) 3.5 Leading Players of Heart Failure Drugs by Type in 2020 3.6 Conclusion of Segment by Type Chapter 4 Heart Failure Drugs Market Segment Analysis by Application 4.1 Global Heart Failure Drugs Market by Application 4.1.1 Hospital Pharmacy 4.1.2 Retail Pharmacy 4.1.3 Online Pharmacy 4.2 Global Heart Failure Drugs Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Heart Failure Drugs by Application in 2020 4.4 Conclusion of Segment by Application Chapter 5 Heart Failure Drugs Market Segment Analysis by Sales Channel 5.1 Global Heart Failure Drugs Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Heart Failure Drugs Revenue and Market Share by Sales Channel (2015-2020) 5.3 Leading Distributors/Dealers of Heart Failure Drugs by Sales Channel in 2020 5.4 Conclusion of Segment by Sales Channel Chapter 6 Heart Failure Drugs Market Segment Analysis by Region 6.1 Global Heart Failure Drugs Market Size and CAGR by Region (2015-2030) 6.2 Global Heart Failure Drugs Sales and Market Share by Region (2015-2020) 6.3 Global Heart Failure Drugs Revenue and Market Share by Region (2015-2020) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Heart Failure Drugs Market Share by Type 6.4.3 North America Heart Failure Drugs Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Heart Failure Drugs Market Share by Type 6.5.3 Europe Heart Failure Drugs Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Heart Failure Drugs Market Share by Type 6.6.3 Asia-Pacific Heart Failure Drugs Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Heart Failure Drugs Market Share by Type 6.7.3 South America Heart Failure Drugs Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Heart Failure Drugs Market Share by Type 6.8.3 Middle East & Africa Heart Failure Drugs Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Heart Failure Drugs Players 7.1 Novartis 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Novartis 7.2 Pfizer 7.3 AstraZeneca 7.4 Hikma 7.5 Teva 7.6 Cipla 7.7 Merck & Co. 7.8 Amgen 7.9 Roche 7.10 Sun Pharma 7.11 Mylan 7.12 Sanofi 7.13 GSK 7.14 Bristol-Myers Squibb 7.15 Bausch Health 7.16 Johnson & Johnson 7.17 Bayer 7.18 Boehringer Inhelheim 7.19 Exelixis 7.20 Lunan Pharmaceutical 7.21 Sinepharm 7.22 CRC 7.23 Hai Ni Pharmaceutical 7.24 Langtian 7.25 NCPC 7.26 Hayao 7.27 Xinhua Group 7.28 Xudong Haipu Pharmaceutical Chapter 8 Upstream and Downstream Analysis of Heart Failure Drugs 8.1 Industrial Chain of Heart Failure Drugs 8.2 Upstream of Heart Failure Drugs 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Heart Failure Drugs 8.3.1 Leading Distributors/Dealers of Heart Failure Drugs 8.3.2 Leading Consumers of Heart Failure Drugs Chapter 9 Development Trend of Heart Failure Drugs (2021-2030) 9.1 Global Heart Failure Drugs Market Size (Sales and Revenue) Forecast (2021-2030) 9.2 Global Heart Failure Drugs Market Size and CAGR Forecast by Region (2021-2030) 9.3 Global Heart Failure Drugs Market Size and CAGR Forecast by Type (2021-2030) 9.4 Global Heart Failure Drugs Market Size and CAGR Forecast by Application (2021-2030) 9.5 Global Heart Failure Drugs Market Size and CAGR Forecast by Sales Channel (2021-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Heart Failure Drugs Example Figure Global Heart Failure Drugs Revenue (Million $) Status and Outlook (2015-2030) Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Region (2015-2030) Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Type (2015-2030) Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Application (2015-2030) Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Sales Channel (2015-2030) Table Global Heart Failure Drugs Sales by Player (2018-2020) Table Global Heart Failure Drugs Sales Market Share by Player (2018-2020) Figure Global Heart Failure Drugs Sales Market Share by Player in 2020 Table Global Heart Failure Drugs Revenue (Million $) by Player (2018-2020) Table Global Heart Failure Drugs Revenue Market Share by Player (2018-2020) Figure Global Heart Failure Drugs Revenue Market Share by Player in 2020 Table Global Heart Failure Drugs Average Price by Player (2018-2020) Figure Global Heart Failure Drugs Average Price by Player in 2020 Figure Global Heart Failure Drugs Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018 Figure Global Heart Failure Drugs Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020 Figure Example of Injection Figure Global Injection Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Capsule Figure Global Capsule Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Tablets Figure Global Tablets Revenue (Million $) and Growth Rate (2015-2020) Table Global Heart Failure Drugs Sales by Type (2015-2020) Table Global Heart Failure Drugs Sales Market Share by Type (2015-2020) Figure Global Heart Failure Drugs Sales Market Share by Type in 2020 Table Global Heart Failure Drugs Revenue (Million $) by Type (2015-2020) Table Global Heart Failure Drugs Revenue Market Share by Type (2015-2020) Figure Global Heart Failure Drugs Revenue Market Share by Type in 2020 Table Global Heart Failure Drugs Average Price by Type (2015-2020) Figure Global Heart Failure Drugs Average Price by Type in 2020 Table Leading Players of Heart Failure Drugs by Type in 2020 Figure Example of Hospital Pharmacy Figure Global Heart Failure Drugs for Hospital Pharmacy Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Retail Pharmacy Figure Global Heart Failure Drugs for Retail Pharmacy Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Online Pharmacy Figure Global Heart Failure Drugs for Online Pharmacy Revenue (Million $) and Growth Rate (2015-2020) Table Global Heart Failure Drugs Sales by Application (2015-2020) Table Global Heart Failure Drugs Sales Market Share by Application (2015-2020) Figure Global Heart Failure Drugs Sales Market Share by Application in 2020 Table Leading Consumers of Heart Failure Drugs by Application in 2020 Figure Example of Direct Channel Figure Global Heart Failure Drugs for Direct Channel Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Distribution Channel Figure Global Heart Failure Drugs for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020) Table Global Heart Failure Drugs Revenue by Sales Channel (2015-2020) Table Global Heart Failure Drugs Revenue Market Share by Sales Channel (2015-2020) Figure Global Heart Failure Drugs Revenue Market Share by Sales Channel in 2020 Table Leading Distributors/Dealers of Heart Failure Drugs by Sales Channel in 2020 Table Global Heart Failure Drugs Market Size and CAGR by Region (2015-2030) Table Global Heart Failure Drugs Sales by Region (2015-2020) Table Global Heart Failure Drugs Sales Market Share by Region (2015-2020) Figure Global Heart Failure Drugs Sales Market Share by Region in 2020 Table Global Heart Failure Drugs Revenue (Million $) by Region (2015-2020) Table Global Heart Failure Drugs Revenue Market Share by Region (2015-2020) Figure Global Heart Failure Drugs Revenue Market Share by Region in 2020 Table North America Heart Failure Drugs Sales by Country (2015-2020) Figure North America Heart Failure Drugs Sales Market Share by Country (2015-2020) Table North America Heart Failure Drugs Revenue by Country (2015-2020) Figure North America Heart Failure Drugs Revenue Market Share by Country (2015-2020) Figure North America Heart Failure Drugs Market Share by Type in 2020 Figure North America Heart Failure Drugs Market Share by Application in 2020 Figure United States Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure United States Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Canada Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Canada Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Mexico Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Mexico Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Table Europe Heart Failure Drugs Sales by Country (2015-2020) Figure Europe Heart Failure Drugs Sales Market Share by Country (2015-2020) Table Europe Heart Failure Drugs Revenue by Country (2015-2020) Figure Europe Heart Failure Drugs Revenue Market Share by Country (2015-2020) Figure Europe Heart Failure Drugs Market Share by Type in 2020 Figure Europe Heart Failure Drugs Market Share by Application in 2020 Figure Germany Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Germany Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure UK Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure UK Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure France Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure France Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Italy Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Italy Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Russia Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Russia Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Spain Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Spain Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Table Asia-Pacific Heart Failure Drugs Sales by Country (2015-2020) Figure Asia-Pacific Heart Failure Drugs Sales Market Share by Country (2015-2020) Table Asia-Pacific Heart Failure Drugs Revenue by Country (2015-2020) Figure Asia-Pacific Heart Failure Drugs Revenue Market Share by Country (2015-2020) Figure Asia-Pacific Heart Failure Drugs Market Share by Type in 2020 Figure Asia-Pacific Heart Failure Drugs Market Share by Application in 2020 Figure China Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure China Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Japan Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Japan Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Korea Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Korea Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure India Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure India Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Southeast Asia Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Southeast Asia Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Australia Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Australia Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Table South America Heart Failure Drugs Sales by Country (2015-2020) Figure South America Heart Failure Drugs Sales Market Share by Country (2015-2020) Table South America Heart Failure Drugs Revenue by Country (2015-2020) Figure South America Heart Failure Drugs Revenue Market Share by Country (2015-2020) Figure South America Heart Failure Drugs Market Share by Type in 2020 Figure South America Heart Failure Drugs Market Share by Application in 2020 Figure Brazil Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Brazil Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Argentina Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Argentina Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Colombia Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Colombia Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Table Middle East & Africa Heart Failure Drugs Sales by Country (2015-2020) Figure Middle East & Africa Heart Failure Drugs Sales Market Share by Country (2015-2020) Table Middle East & Africa Heart Failure Drugs Revenue by Country (2015-2020) Figure Middle East & Africa Heart Failure Drugs Revenue Market Share by Country (2015-2020) Figure Middle East & Africa Heart Failure Drugs Market Share by Type in 2020 Figure Middle East & Africa Heart Failure Drugs Market Share by Application in 2020 Figure UAE Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure UAE Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure Saudi Arabia Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Figure South Africa Heart Failure Drugs Sales and Growth Rate (2015-2020) Figure South Africa Heart Failure Drugs Revenue (Million $) and Growth Rate (2015-2020) Table Company Snapshot of Novartis Table Heart Failure Drugs Introduction of Novartis Table Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share of Novartis (2018-2020) Table Industrial Chain of Heart Failure Drugs Table Manufacturing Cost Structure of Heart Failure Drugs Table General Manufacturing Process of Heart Failure Drugs Table Leading Distributors/Dealers of Heart Failure Drugs Table Leading Consumers of Heart Failure Drugs Figure Global Heart Failure Drugs Sales and Growth Rate Forecast (2021-2030) Figure Global Heart Failure Drugs Revenue and Growth Rate Forecast (2021-2030) Table Global Heart Failure Drugs Market Size and CAGR Forecast by Region (2021-2030) Table Global Heart Failure Drugs Market Size and CAGR Forecast by Type (2021-2030) Table Global Heart Failure Drugs Market Size and CAGR Forecast by Application (2021-2030) Table Global Heart Failure Drugs Market Size and CAGR Forecast by Sales Channel (2021-2030)

Leading players of Heart Failure Drugs including: Novartis Pfizer AstraZeneca Hikma Teva Cipla Merck & Co. Amgen Roche Sun Pharma Mylan Sanofi GSK Bristol-Myers Squibb Bausch Health Johnson & Johnson Bayer Boehringer Inhelheim Exelixis Lunan Pharmaceutical Sinepharm CRC Hai Ni Pharmaceutical Langtian NCPC Hayao Xinhua Group Xudong Haipu Pharmaceutical